|
|
Volumn 9, Issue 2, 2000, Pages 371-382
|
|
Pharmacology and clinical experience with amprenavir
a
|
|
Author keywords
Amprenavir; Antiretroviral drugs; Combination therapy; Drug resistance; Drug toxicity; Highly active antiretrovrial therapy; Pharmacokinetics; Protease inhibitors
|
|
Indexed keywords
ABACAVIR;
AMIODARONE;
AMPRENAVIR;
ANTIRETROVIRUS AGENT;
BEPRIDIL;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
ERGOT DERIVATIVE;
INDINAVIR;
KETOCONAZOLE;
LAMIVUDINE;
LIDOCAINE;
MIDAZOLAM;
NELFINAVIR;
NEVIRAPINE;
PRODRUG;
PROTEINASE INHIBITOR;
QUINIDINE;
RIFABUTIN;
RIFAMPICIN;
RITONAVIR;
SAQUINAVIR;
SILDENAFIL;
STAVUDINE;
TRIAZOLAM;
TRICYCLIC ANTIDEPRESSANT AGENT;
WARFARIN;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CHEMICAL STRUCTURE;
DIARRHEA;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG TOXICITY;
FATIGUE;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
PARESTHESIA;
PHARMACODYNAMICS;
PHARMACOKINETICS;
RASH;
REVIEW;
VOMITING;
|
|
EID: 0033974115
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.2.371 Document Type: Review |
|
Times cited : (11)
|
|
References (104)
|
